Combination Chemotherapy in Treating Patients With Refractory or Recurrent Solid Tumors
Status:
Completed
Trial end date:
2001-10-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: Phase I trial to study the effectiveness of combination chemotherapy with paclitaxel
and cisplatin plus flavopiridol in treating patients who have refractory or recurrent solid
tumors.